Thomas
Cook: So, the old ‘un has a new girlfriend after over 170 years of
romantic twists and turns. The newbie is a twenty-something year old Chinese
conglomerate, Fosun. They are taking a 5% stake in Thomas Cook at a cost of
£91.8m, (which works out at 125.59p per share) and are looking to buy more
shares in the open market to take the stake to 10%. As well as offering stronger
financial backing, the deal opens the door to deepening existing relationships
with Fosun’s recently acquired ClubMed business, an acceleration of the rollout
of Thomas Cook’s Concept Hotel brand and the chance to better access the
Chinese tourism market. It sounds as if existing shareholders pushed back on a
proposal for the entire 10% stake to be via new shares, due to the dilutive
effect.
The shares rocketed up on Friday’s news,
settling today around 145p. Whilst Fosun build their stake, I guess the shares will
be underpinned around here. At this level a possible 12.5p of earnings this
year (to 30th September 2015) is a PE of 11.6x, with maybe 15.5p in
FY2016 being 9.4x a year out. These are using pre-deal forecasts with the group
implying some eps enhancement in FY2015 and then further benefits in FY2016,
which some seem think too over-ambitious a timeline. Anyway, with debt coming
down and the balance sheet stabilising a return to the dividend list looks
likely this year, albeit a token amount. However, a conservative three times
cover in FY2016, leads to a possible 5.2p dividend that year for a yield of
3.6%. This looks ahead of consensus, so I might be getting carried away, but
the potential is there. Longer term, the question is whether Fosun will want
full ownership. Due to EU rules, Thomas Cook would have to get rid of their
airline business on a non-European takeover, but that may suit them anyway. So
the real question is how long investors might have to wait. It may be a while,
but with Thomas Cook on the mend and a new girlfriend on its arm, patience
should be rewarded. (Neil Cumming, 9th March 2015)
No comments:
Post a Comment